Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Chen

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Reproductive Health|October 11, 2013
Informing HIV prevention efforts targeting Liberian youth: a study using the PLACE method in LiberiaDonna R McCarraher, Mario Chen, Sam Wambugu, et al.
The Lancet. Global Health|March 13, 2018
Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: a randomised controlled trialHolly M Burke, Mario Chen, Mercy Buluzi, et al.
Contraception|May 15, 2018
Women's satisfaction, use, storage and disposal of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) during a randomized trialHolly M Burke, Mario Chen, Mercy Buluzi, et al.
Global Health, Science and Practice|March 22, 2019
Factors Affecting Continued Use of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC): A Secondary Analysis of a 1-Year Randomized Trial in MalawiHolly M Burke, Mario Chen, Mercy Buluzi, et al.
Journal of Biosocial Science|March 9, 2010
Meeting the needs of adolescent post-abortion care patients in the Dominican RepublicDonna R McCarraher, Mario Chen-Mok, Ana Sophia Oronoz, et al.
The Cochrane Database of Systematic Reviews|August 19, 2016
Hormonal contraceptives for contraception in overweight or obese womenLaureen M Lopez, Alissa Bernholc, Mario Chen, et al.
Global Health, Science and Practice|July 2, 2020
What Goes In Must Come Out: A Mixed-Method Study of Access to Contraceptive Implant Removal Services in GhanaRebecca Callahan, Elena Lebetkin, Claire Brennan, et al.
Plos One|December 2, 2021
Improved HIV case finding among key populations after differentiated data driven community testing approaches in ZambiaJoseph Kamanga, Kayla Stankevitz, Andres Martinez, et al.
BMJ Global Health|October 23, 2025
The case for investing in provider-administered subcutaneous DMPA: a costing studyHolly M Burke, Wingston Felix Ng'ambi, Rick Homan, et al.
The American Journal of Tropical Medicine and Hygiene|February 5, 2011
Phase I safety and immunogenicity trial of Plasmodium vivax CS derived long synthetic peptides adjuvanted with montanide ISA 720 or montanide ISA 51Sócrates Herrera, Olga Lucía Fernández, Omaira Vera, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Reproductive Health|October 11, 2013
Informing HIV prevention efforts targeting Liberian youth: a study using the PLACE method in LiberiaDonna R McCarraher, Mario Chen, Sam Wambugu, et al.
The Lancet. Global Health|March 13, 2018
Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: a randomised controlled trialHolly M Burke, Mario Chen, Mercy Buluzi, et al.
Contraception|May 15, 2018
Women's satisfaction, use, storage and disposal of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) during a randomized trialHolly M Burke, Mario Chen, Mercy Buluzi, et al.
Global Health, Science and Practice|March 22, 2019
Factors Affecting Continued Use of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC): A Secondary Analysis of a 1-Year Randomized Trial in MalawiHolly M Burke, Mario Chen, Mercy Buluzi, et al.
Journal of Biosocial Science|March 9, 2010
Meeting the needs of adolescent post-abortion care patients in the Dominican RepublicDonna R McCarraher, Mario Chen-Mok, Ana Sophia Oronoz, et al.
The Cochrane Database of Systematic Reviews|August 19, 2016
Hormonal contraceptives for contraception in overweight or obese womenLaureen M Lopez, Alissa Bernholc, Mario Chen, et al.
Global Health, Science and Practice|July 2, 2020
What Goes In Must Come Out: A Mixed-Method Study of Access to Contraceptive Implant Removal Services in GhanaRebecca Callahan, Elena Lebetkin, Claire Brennan, et al.
Plos One|December 2, 2021
Improved HIV case finding among key populations after differentiated data driven community testing approaches in ZambiaJoseph Kamanga, Kayla Stankevitz, Andres Martinez, et al.
BMJ Global Health|October 23, 2025
The case for investing in provider-administered subcutaneous DMPA: a costing studyHolly M Burke, Wingston Felix Ng'ambi, Rick Homan, et al.
The American Journal of Tropical Medicine and Hygiene|February 5, 2011
Phase I safety and immunogenicity trial of Plasmodium vivax CS derived long synthetic peptides adjuvanted with montanide ISA 720 or montanide ISA 51Sócrates Herrera, Olga Lucía Fernández, Omaira Vera, et al.
Pageof 10